Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in Vivo

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Virtue, Sam ^a   Masoodi, Mojgan ^b   Velagapudi, Vidya ^c   Tan, Chong Yew ^a   Dale, Martin ^a   Suorti, Tapani ^c   Slawik, Marc ^d   Blount, Margaret ^a   Burling, Keith ^a   Campbell, Mark ^a   Eguchi, Naomi ^e   Medina Gomez, Gema ^f   Sethi, Jaswinder K ^a   Orešič, Matej ^c   Urade, Yoshihiro ^e   Griffin, Julian L ^b   Vidal Puig, Antonio ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e OSAKA BIOSCIENCE INSTITUTE   (Japan)

^f UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ARGINASE 1; CD209 ANTIGEN; CD209A ANTIGEN; CD3 ANTIGEN; CD3E ANTIGEN; CD3G ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; F480 ANTIGEN; FATTY ACID; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN P 15095; HORMONE SENSITIVE LIPASE; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; LIPASE ATGL; LIPOCALIN PROSTAGLANDIN D SYNTHASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROSTAGLANDIN D SYNTHASE; RANTES; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME REGULATION; EPIDIDYMAL WHITE ADIPOSE TISSUE; FATTY ACID BLOOD LEVEL; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; IN VIVO STUDY; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; LIPID METABOLISM; LIPID OXIDATION; LIPOLYSIS; LUNG GAS EXCHANGE; MALE; METABOLIC RATE; METABOLIC REGULATION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; SUBCUTANEOUS WHITE ADIPOSE TISSUE; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BIOLOGICAL MARKERS; CARBOHYDRATE METABOLISM; EICOSANOIDS; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; INTRAMOLECULAR OXIDOREDUCTASES; LIPID METABOLISM; LIPOCALINS; LIPOGENESIS; LIVER; MALE; MICE; MICE, KNOCKOUT; PPAR GAMMA; RNA, MESSENGER; SUBCUTANEOUS FAT;

MUS;

EID: 84863613745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039512     Document Type: Article

References (36)

1. Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, et al. (2005) The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes 54: 1706-1716.
2. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, et al. (1999) PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585-595.
3. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, et al. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99: 2416-2422.
4. Werman A, Hollenberg A, Solanes G, Bjorbaek C, Vidal-Puig AJ, et al. (1997) Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and-2 isoforms and influence of insulin. J Biol Chem 272: 20230-20235.
5. Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, et al. (2007) PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3: e64.
6. Zhang J, Fu M, Cui T, Xiong C, Xu K, et al. (2004) Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity. Proc Natl Acad Sci U S A 101: 10703-10708.
7. Gray SL, Nora ED, Grosse J, Manieri M, Stoeger T, et al. (2006) Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55: 2669-2677.
8. Tan GD, Savage DB, Fielding BA, Collins J, Hodson L, et al. (2008) Fatty acid metabolism in patients with PPARgamma mutations. J Clin Endocrinol Metab 93: 4462-4470.
9. Basu A, Basu R, Shah P, Vella A, Rizza RA, et al. (2001) Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 280: E1000-1006.
10. Manolopoulos KN, Karpe F, Frayn KN, (2010) Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 34: 949-959.
11. Rocha PM, Barata JT, Teixeira PJ, Ross R, Sardinha LB, (2008) Independent and opposite associations of hip and waist circumference with metabolic syndrome components and with inflammatory and atherothrombotic risk factors in overweight and obese women. Metabolism 57: 1315-1322.
12. Gray SL, Dalla Nora E, Backlund EC, Manieri M, Virtue S, et al. (2006) Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARgamma) function. Endocrinology 147: 5708-5714.
13. Virtue S, Vidal-Puig A, (2010) Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective. Biochim Biophys Acta 1801: 338-349.
14. Virtue S, Vidal-Puig A, (2008) It's not how fat you are, it's what you do with it that counts. PLoS Biol 6: e237.
15. Urade Y, Eguchi N, (2002) Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat 68-69: 375-382.
16. Inoue T, Eguchi Y, Matsumoto T, Kijima Y, Kato Y, et al. (2008) Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis 201: 385-391.
17. Tanaka R, Miwa Y, Mou K, Tomikawa M, Eguchi N, et al. (2009) Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice. Biochem Biophys Res Commun 378: 851-856.
18. Ragolia L, Palaia T, Hall CE, Maesaka JK, Eguchi N, et al. (2005) Accelerated glucose intolerance, nephropathy and atherosclerosis in prostaglandin D2 synthase knockout mice. J Biol Chem.
19. Quinkler M, Bujalska IJ, Tomlinson JW, Smith DM, Stewart PM, (2006) Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis. Gene 380: 137-143.
20. Eguchi N, Minami T, Shirafuji N, Kanaoka Y, Tanaka T, et al. (1999) Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci U S A 96: 726-730.
21. Alberts P, Johansson BG, McArthur RA, (2006) Characterization of energy expenditure in rodents by indirect calorimetry. Curr Protoc Neurosci Chapter 9: Unit9 23D.
22. Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J, (2008) Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295: E1323-1332.
23. Masoodi M, Nicolaou A, Gledhill K, Rhodes LE, Tobin DJ, et al. (2010) Prostaglandin D production in FM55 melanoma cells is regulated by alpha-melanocyte-stimulating hormone and is not related to melanin production. Exp Dermatol 19: 751-753.
24. Masoodi M, Eiden M, Koulman A, Spaner D, Volmer DA, (2010) Comprehensive lipidomics analysis of bioactive lipids in complex regulatory networks. Anal Chem 82: 8176-8185.
25. Laaksonen T, Pelliniemi O, Quinn BM, (2006) Ion permeability of SAMs on nanoparticle surfaces. J Am Chem Soc 128: 14341-14346.
26. Katajamaa M, Miettinen J, Oresic M, (2006) MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22: 634-636.
27. Rodriguez-Cuenca S, Carobbio S, Vidal-Puig A, (2012) Ablation of Pparg2 impairs lipolysis and reveals murine strain differences in lipolytic responses. FASEB J.
28. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, et al. (1998) Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47: 98-103.
29. O'Rourke RW, Metcalf MD, White AE, Madala A, Winters BR, et al. (2009) Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int J Obes (Lond) 33: 978-990.
30. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, et al. (2010) Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 120: 3466-3479.
31. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
32. Frayn KN, (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45: 1201-1210.
33. Han MS, Lim YM, Quan W, Kim JR, Chung KW, et al. (2011) Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 52: 1234-1246.
34. Pietilainen KH, Rog T, Seppanen-Laakso T, Virtue S, Gopalacharyulu P, et al. (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 9: e1000623.
35. Pinzar E, Kanaoka Y, Inui T, Eguchi N, Urade Y, et al. (2000) Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci U S A 97: 4903-4907.
36. Beuckmann CT, Aoyagi M, Okazaki I, Hiroike T, Toh H, et al. (1999) Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase. Biochemistry 38: 8006-8013.